{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T19:36:07Z","timestamp":1794857767348,"version":"4.9.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Chemistry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Green analytical chemistry principles, as well as experimental design, are a combined approach adopted to develop sensitive reproducible stability indicating HPLC method for Zonisamide (ZNS) determination. The optimal conditions for three chromatographic parameters were determined using a central composite design of the response surface. Kromasil C\n                    <jats:sub>18<\/jats:sub>\n                    column (150\u00a0mm\u2009\u00d7\u20094.6\u00a0mm, 5\u00a0\u00b5m) was utilized with ethanol, H\n                    <jats:sub>2<\/jats:sub>\n                    O (30:70 v\/v) as a mobile phase at a flow rate of 1\u00a0mL\/min at 35\u00a0\u00b0C. Good reproducibility and high sensitivity were achieved along (0.5\u201310\u00a0\u00b5g\/mL) concentration range. In contrast, the TLC-densitometric method was performed on aluminum plates precoated with silica gel 60F\n                    <jats:sub>254<\/jats:sub>\n                    as a stationary phase and chloroform: methanol: acetic acid (8:1.5:0.5 by volume) as a developing system. Reproducible results were obtained in the range of (2\u201310\u00a0\u03bcg\/band). The chromatograms of HPLC and TLC were scanned at 280\u00a0nm and 240\u00a0nm, respectively. The suggested methods have been validated following ICH guidelines, and no statistically significant differences were detected between the results of the current study and the official USP method. It was also found that using experimental design implements the green concept by reducing the environmental impact. Finally, Eco-Scale, GAPI and AGREE were used to assess the environmental impacts of the suggested methods.\n                  <\/jats:p>","DOI":"10.1186\/s13065-023-00942-1","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T02:02:24Z","timestamp":1681696944000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Green analytical chemistry and experimental design: a combined approach for the analysis of zonisamide"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4356-3762","authenticated-orcid":false,"given":"Soha G.","family":"Elsheikh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3234-9883","authenticated-orcid":false,"given":"Abeer M. E.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4446-0853","authenticated-orcid":false,"given":"Yasmin M.","family":"Fayez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6295-3697","authenticated-orcid":false,"given":"Sally S.","family":"El-Mosallamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,17]]},"reference":[{"key":"942_CR1","first-page":"29","volume-title":"Green chemistry: theory and practice","author":"PT Anastas","year":"1998","unstructured":"Anastas PT, Warner JC. Green chemistry: theory and practice. Oxford: Oxford University Press; 1998. p. 29\u201356."},{"key":"942_CR2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.20902\/IJCTR.2018.111036","volume":"11","author":"S Ravichandran","year":"2018","unstructured":"Ravichandran S. Environmental pollution control through green chemistry. Int J Chem Tech Res. 2018;11:293\u20137. https:\/\/doi.org\/10.20902\/IJCTR.2018.111036.","journal-title":"Int J Chem Tech Res"},{"key":"942_CR3","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/jaoacint\/qsab132","volume":"2","author":"SG Elsheikh","year":"2021","unstructured":"Elsheikh SG, Hassan AM, Fayez YM, El-Mosallamy SS. Greenness assessment of two validated stability-indicating chromatographic methods for estimating modafinil using the analytical Eco-Scale. J AOAC Int. 2021;2:379\u201386. https:\/\/doi.org\/10.1093\/jaoacint\/qsab132.","journal-title":"J AOAC Int"},{"key":"942_CR4","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.jpba.2017.05.006","volume":"147","author":"PK Sahu","year":"2018","unstructured":"Sahu PK, Ramisetti NR, Cecchi T, Swain S, Patro CS, Panda J. An overview of experimental designs in HPLC method development and validation. J Pharm Biomed Anal. 2018;147:590\u2013611. https:\/\/doi.org\/10.1016\/j.jpba.2017.05.006.","journal-title":"J Pharm Biomed Anal"},{"key":"942_CR5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jpba.2014.03.035","volume":"96","author":"M Kurmi","year":"2014","unstructured":"Kurmi M, Kumar S, Singh B, Singh S. Implementation of design of experiments for optimization of forced degradation conditions and development of a stability-indicating method for furosemide. J Pharm Biomed Anal. 2014;96:135\u201343. https:\/\/doi.org\/10.1016\/j.jpba.2014.03.035.","journal-title":"J Pharm Biomed Anal"},{"key":"942_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4172\/pharmaceutical-sciences.1000478","volume":"81","author":"K Veerubhotla","year":"2019","unstructured":"Veerubhotla K, Walker R. Development and validation of a stability-indicating RP-HPLC method using quality by design for estimating captopril. Indian J Pharm Sci. 2019;81:45\u201356. https:\/\/doi.org\/10.4172\/pharmaceutical-sciences.1000478.","journal-title":"Indian J Pharm Sci"},{"key":"942_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcoa.2022.100052","author":"K Kokilambigai","year":"2022","unstructured":"Kokilambigai K, Lakshmi K. Analytical quality by design assisted RP-HPLC method for quantifying atorvastatin with green analyical chemistry perspective. J Chromatogr A. 2022. https:\/\/doi.org\/10.1016\/j.jcoa.2022.100052.","journal-title":"J Chromatogr A"},{"key":"942_CR8","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2174\/1573411013666170615140836","volume":"14","author":"S Saroj","year":"2018","unstructured":"Saroj S, Shah P, Jairaj V, Rathod R. Green analytical chemistry and quality by design: a combined approach towards robust and sustainable modern analysis. Curr Anal Chem. 2018;14:367\u201381. https:\/\/doi.org\/10.2174\/1573411013666170615140836.","journal-title":"Curr Anal Chem"},{"key":"942_CR9","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1556\/1006.2018.31.6.8","volume":"31","author":"PB Prajapati","year":"2018","unstructured":"Prajapati PB, Bodiwala KB, Shah SA. Analytical quality-by-design approach for the stability study of thiocolchicoside by eco-friendly chromatographic method. JPC-J Planar Chromat. 2018;31:477\u201387. https:\/\/doi.org\/10.1556\/1006.2018.31.6.8.","journal-title":"JPC-J Planar Chromat"},{"key":"942_CR10","unstructured":"United States Pharmacopeia and National Formulary (USP 37\u2013NF 32), United States Pharmacopeial convention, Rockville. 2014."},{"key":"942_CR11","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/j.seizure.2004.04.016","volume":"13","author":"IE Leppik","year":"2004","unstructured":"Leppik IE. Zonisamide: chemistry, mechanism of action, and pharmacokinetics. Seizure. 2004;13:S5\u20139. https:\/\/doi.org\/10.1016\/j.seizure.2004.04.016.","journal-title":"Seizure"},{"key":"942_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/s0920-1211(97)00097-1","volume":"30","author":"A Mori","year":"1998","unstructured":"Mori A, Noda Y, Packer L. The anticonvulsant Zonisamide scavenges free radicals. Epilepsy Res. 1998;30:153\u20138. https:\/\/doi.org\/10.1016\/s0920-1211(97)00097-1.","journal-title":"Epilepsy Res"},{"key":"942_CR13","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.jpba.2006.02.044","volume":"41","author":"T Yoshida","year":"2006","unstructured":"Yoshida T, Imai K, Motohashi S, Hamano S-I, Sato M. Simultaneous determination of Zonisamide, carbamazepine and carbamazepine-10, 11-epoxide in infant serum by high-performance liquid chromatography. J Pharm Biomed Anal. 2006;41:1386\u201390. https:\/\/doi.org\/10.1016\/j.jpba.2006.02.044.","journal-title":"J Pharm Biomed Anal"},{"key":"942_CR14","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/bmc.753","volume":"21","author":"E Greiner-Sosanko","year":"2007","unstructured":"Greiner-Sosanko E, Lower DR, Virji MA, Krasowski MD. Simultaneous determination of Lamotrigine, Zonisamide, and carbamazepine in human plasma by high-performance liquid chromatography. Biomed Chromatogr. 2007;21:225\u20138. https:\/\/doi.org\/10.1002\/bmc.753.","journal-title":"Biomed Chromatogr"},{"key":"942_CR15","doi-asserted-by":"publisher","first-page":"360","DOI":"10.4103\/0250-474X.107073","volume":"74","author":"M Majnooni","year":"2012","unstructured":"Majnooni M, Mohammadi B, Jalili R, Bahrami G. Rapid and sensitive high performance liquid chromatographic determination of Zonisamide in human serum application to a pharmacokinetic study. Indian J Pharm Sci. 2012;74:360\u20134. https:\/\/doi.org\/10.4103\/0250-474X.107073.","journal-title":"Indian J Pharm Sci"},{"key":"942_CR16","first-page":"1449","volume":"6","author":"S Meyyanathan","year":"2022","unstructured":"Meyyanathan S, Bandla R, Babu B, Kalaivani M. HPLC method for the estimation of Zonisamide in its formulation. J Posit Psychol. 2022;6:1449\u201352.","journal-title":"J Posit Psychol"},{"key":"942_CR17","first-page":"196","volume":"7","author":"S Nimbokar","year":"2021","unstructured":"Nimbokar S, Badukale N, Panchale W, Bakal R, Gudalwar B, Manwar J. Development and validation of RP-HPLC method for determination of zonisamide from tablet formulation. World J Pharm Res. 2021;7:196\u2013200.","journal-title":"World J Pharm Res"},{"issue":"15","key":"942_CR18","doi-asserted-by":"publisher","first-page":"4899","DOI":"10.3390\/molecules27154899","volume":"27","author":"M Rmandi\u0107","year":"2022","unstructured":"Rmandi\u0107 M, Staji\u0107 A, Jan\u010di\u0107 J, Samard\u017ei\u0107 J, Jovi\u0107 N, Malenovi\u0107 A. Quantification of Zonisamide in dried blood spots and dried plasma spots by UPLC\u2013MS\/MS: application to clinical practice. Molecules. 2022;27(15):4899. https:\/\/doi.org\/10.3390\/molecules27154899.","journal-title":"Molecules"},{"key":"942_CR19","first-page":"157","volume":"2","author":"B Paw","year":"2008","unstructured":"Paw B, Wos K. Development and validation of a capillary electrophoresis method for determination of Oxcarbazepine and Zonisamide in pharmaceuticals. J Pre-Clin Clin Res. 2008;2:157\u20139.","journal-title":"J Pre-Clin Clin Res"},{"key":"942_CR20","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1002\/elps.1150191611","volume":"19","author":"Y Kataoka","year":"1998","unstructured":"Kataoka Y, Makino K, Oishi R. Capillary electrophoresis for therapeutic drug monitoring of antiepileptics. J Electrophor. 1998;19:2856\u201360. https:\/\/doi.org\/10.1002\/elps.1150191611.","journal-title":"J Electrophor"},{"key":"942_CR21","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.jpba.2011.07.018","volume":"56","author":"L Antonilli","year":"2011","unstructured":"Antonilli L, Brusadin V, Filipponi F, Guglielmi R, Nencini P. Development and validation of an analytical method based on high performance thin layer chromatography for the simultaneous determination of lamotrigine, zonisamide and levetiracetam in human plasma. J Pharm Biomed Anal. 2011;56:763\u201370. https:\/\/doi.org\/10.1016\/j.jpba.2011.07.018.","journal-title":"J Pharm Biomed Anal"},{"key":"942_CR22","doi-asserted-by":"publisher","first-page":"385","DOI":"10.36468\/pharmaceutical-sciences.521","volume":"81","author":"RP Munshi","year":"2019","unstructured":"Munshi RP, Gawde N. Development and validation of a HPTLC method to determine serum Zonisamide levels for therapeutic drug monitoring in clinical settings. Indian J Pharm Sci. 2019;81:385\u20139. https:\/\/doi.org\/10.36468\/pharmaceutical-sciences.521.","journal-title":"Indian J Pharm Sci"},{"key":"942_CR23","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1080\/00032710903325799","volume":"43","author":"MB Gholivand","year":"2010","unstructured":"Gholivand MB, Khodadadian M, Majnooni MB, Bahrami G. Electroreduction of Zonisamide at hanging mercury drop electrode and its determination in pharmaceutical formulations and spiked human serum samples. Anal Lett. 2010;43:269\u201379. https:\/\/doi.org\/10.1080\/00032710903325799.","journal-title":"Anal Lett"},{"key":"942_CR24","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1365\/s10337-006-0024-6","volume":"64","author":"D Rao","year":"2006","unstructured":"Rao D, Chakravarthy I, Kumar S. Stability indicating HPLC method for the determination of Zonisamide as bulk drug and in pharmaceutical dosage form. Chromatographia. 2006;64:261\u20136. https:\/\/doi.org\/10.1365\/s10337-006-0024-6.","journal-title":"Chromatographia"},{"key":"942_CR25","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.20959\/wjpps20179-10069","volume":"6","author":"RD Wani","year":"2017","unstructured":"Wani RD, Gaikwad BP, Bairagi SH. Development and stability indicating studies of Zonisamide by RP-HPLC method in capsule dosage form. World J Pharm Sci. 2017;6:1480\u20137. https:\/\/doi.org\/10.20959\/wjpps20179-10069.","journal-title":"World J Pharm Sci"},{"key":"942_CR26","doi-asserted-by":"publisher","first-page":"302","DOI":"10.4103\/0250-474X.70474","volume":"72","author":"M Hosseini","year":"2010","unstructured":"Hosseini M, Alipour E, Farokhsir A. Determination and validation of zonisamide and its four related substances by HPLC and UV-spectrophotometry. Indian J Pharm Sci. 2010;72:302\u20136. https:\/\/doi.org\/10.4103\/0250-474X.70474.","journal-title":"Indian J Pharm Sci"},{"key":"942_CR27","first-page":"832","volume":"7","author":"P Raghuram","year":"2008","unstructured":"Raghuram P, Raju IS, Sriramulu J. A rapid stability indicating LC method for Zonisamide using RR-LC. Anal chem\u202f: Indian j. 2008;7:832\u20138.","journal-title":"Anal chem : Indian j"},{"key":"942_CR28","doi-asserted-by":"publisher","first-page":"521","DOI":"10.4103\/0250-474X.58183","volume":"71","author":"E Vijayakumar","year":"2009","unstructured":"Vijayakumar E, Dhore D, Kumar M. HPLC method for simultaneous determination of impurities and degradation products in Zonisamide. Indian J Pharm Sci. 2009;71:521\u20136. https:\/\/doi.org\/10.4103\/0250-474X.58183.","journal-title":"Indian J Pharm Sci"},{"key":"942_CR29","first-page":"57","volume":"3","author":"TA Divan","year":"2013","unstructured":"Divan TA, Patel BA, Parmar SJ. Development and validation of simple UV spectroscopic method for estimation of Zonisamide in bulk and pharmaceutical Dosgae form. Int J Pharm Biol Sci. 2013;3:57\u201363.","journal-title":"Int J Pharm Biol Sci"},{"key":"942_CR30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1166\/rase.2013.1039","volume":"2","author":"ZA Alothman","year":"2013","unstructured":"Alothman ZA, Rahman N, Siddiqui MR. Review on pharmaceutical impurities, stability studies and degradation products: an analytical approach. Rev Adv Sci Eng. 2013;2:155\u201366. https:\/\/doi.org\/10.1166\/rase.2013.1039.","journal-title":"Rev Adv Sci Eng"},{"key":"942_CR31","first-page":"1231","volume":"3","author":"M Kaur","year":"2013","unstructured":"Kaur M, Kaur G, Kaur H, Sharma S. Overview on stability Studies. Int J Pharm Chem Biol Sci. 2013;3:1231\u201341.","journal-title":"Int J Pharm Chem Biol Sci"},{"key":"942_CR32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/chromsci\/bms200","volume":"52","author":"M Sharma","year":"2014","unstructured":"Sharma M, Kothari C, Sherikar O, Mehta P. Concurrent estimation of amlodipine besylate, hydrochlorothiazide and valsartan by RP-HPLC, HPTLC and UV\u2013spectrophotometry. J Chromatogr Sci. 2014;52:27\u201335. https:\/\/doi.org\/10.1093\/chromsci\/bms200.","journal-title":"J Chromatogr Sci"},{"key":"942_CR33","first-page":"204","volume":"2","author":"Z Zaheer","year":"2008","unstructured":"Zaheer Z, Farooqui M, Nikalje AMA. Stability-indicating high performance liquid chromatographic determination of atorvastatin calcium in pharmaceutical dosage form. Afr J Pharm Pharmacol. 2008;2:204\u201310.","journal-title":"Afr J Pharm Pharmacol"},{"key":"942_CR34","doi-asserted-by":"publisher","first-page":"S373","DOI":"10.1016\/j.jscs.2014.04.004","volume":"21","author":"PD Kalariya","year":"2017","unstructured":"Kalariya PD, Namdev D, Srinivas R, Gananadhamu S. Application of experimental design and response surface technique for selecting the optimum RP-HPLC conditions for the determination of moxifloxacin HCl and ketorolac tromethamine in eye drops. J Saudi Chem Soc. 2017;21:S373\u201382. https:\/\/doi.org\/10.1016\/j.jscs.2014.04.004.","journal-title":"J Saudi Chem Soc"},{"key":"942_CR35","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jsps.2015.02.001","volume":"23","author":"L Kumar","year":"2015","unstructured":"Kumar L, Reddy MS, Managuli RS, Pai G. Full factorial design for optimization, development and validation of HPLC method to determine valsartan in nanoparticles. Saudi Pharm J. 2015;23:549\u201355. https:\/\/doi.org\/10.1016\/j.jsps.2015.02.001.","journal-title":"Saudi Pharm J"},{"key":"942_CR36","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s12247-020-09506-5","volume":"17","author":"PB Prajapati","year":"2020","unstructured":"Prajapati PB, Radadiya K, Shah SA. Quality risk management based: analytical quality by design approach to eco-friendly and versatile chromatography method for simultaneous estimation of multiple fixed-dose-combination products of anti-diabetic drugs. J Pharm Innov. 2020;17:111\u201328. https:\/\/doi.org\/10.1007\/s12247-020-09506-5.","journal-title":"J Pharm Innov"},{"key":"942_CR37","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s12247-020-09490-w","volume":"17","author":"P Prajapati","year":"2020","unstructured":"Prajapati P, Shah H, Shah SA. Implementation of QRM and DoE-based quality by design approach to VEER chromatography method for simultaneous estimation of multiple combined dosage forms of paracetamol. J Pharm Innov. 2020;17:2\u201318. https:\/\/doi.org\/10.1007\/s12247-020-09490-w.","journal-title":"J Pharm Innov"},{"key":"942_CR38","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1093\/chromsci\/bmab123","volume":"60","author":"P Prajapati","year":"2022","unstructured":"Prajapati P, Patel A, Shah S. DoE-based analytical quality risk management for enhanced AQbD approach to economical and eco-friendly RP-HPLC method for synchronous estimation of multiple FDC products of antihypertensive drugs. J Chromatogr Sci. 2022;60:786\u201399. https:\/\/doi.org\/10.1093\/chromsci\/bmab123.","journal-title":"J Chromatogr Sci"},{"key":"942_CR39","doi-asserted-by":"publisher","DOI":"10.1093\/jaoacint\/qsac086","author":"P Prajapati","year":"2022","unstructured":"Prajapati P, Shahi A, Acharya A, Shah S. Chemometric and design of experiments-based analytical quality by design and green chemistry approaches to multipurpose high-pressure liquid chromatographic method for synchronous estimation of multiple fixed-dose combinations of azilsartan medoxomil. J AOAC Int. 2022. https:\/\/doi.org\/10.1093\/jaoacint\/qsac086.","journal-title":"J AOAC Int"},{"key":"942_CR40","unstructured":"ICH. Q2 (R1): validation of analytical procedures: text and methodology. In: International Conference on Harmonization, Geneva, 2005."},{"key":"942_CR41","first-page":"1698","volume":"9","author":"KA Reddy","year":"2011","unstructured":"Reddy KA. Determination of zonisamide in capsule dosage form by using RP-HPLC. Int J Chem Sci. 2011;9:1698\u2013704.","journal-title":"Int J Chem Sci"},{"key":"942_CR42","doi-asserted-by":"publisher","first-page":"94","DOI":"10.7324\/JAPS.2012.2515","volume":"2","author":"BU Rao","year":"2012","unstructured":"Rao BU, Nikalje AP. Determination of furosemide and Zonisamide as a drug substance and in dosage form by ion pair-reversed phase liquid chromatographic technique. J Appl Pharm Sci. 2012;2:94\u20139. https:\/\/doi.org\/10.7324\/JAPS.2012.2515.","journal-title":"J Appl Pharm Sci"},{"key":"942_CR43","unstructured":"American Chemical Society (Green Chemical Institute\u00ae). ACS GCI Pharmaceutical Roundtable Solvent Selection Guide. www.acs.org\/gcipharmaroundtablehttp:\/\/www.acs.org\/content\/acs\/en\/greenchemistry\/research-innovation\/tools-for-green-chemistry.html. Accessed 21 Mar 2011."},{"key":"942_CR44","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/reel.12083","volume":"23","author":"L Bergkamp","year":"2014","unstructured":"Bergkamp L, Herbatschek N. Regulating chemical substances under REACH: the choice between authorization and restriction and the case of dipolar aprotic solvents. Rev Eur Comp Int Environ Law. 2014;23:221\u201345. https:\/\/doi.org\/10.1111\/reel.12083.","journal-title":"Rev Eur Comp Int Environ Law"},{"key":"942_CR45","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.trac.2012.03.013","volume":"37","author":"A Ga\u0142uszka","year":"2012","unstructured":"Ga\u0142uszka A, Migaszewski ZM, Konieczka P, Namie\u015bnik J. Analytical Eco-Scale for assessing the greenness of analytical procedures. Trends Analyt Chem. 2012;37:61\u201372. https:\/\/doi.org\/10.1016\/j.trac.2012.03.013.","journal-title":"Trends Analyt Chem"},{"key":"942_CR46","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1039\/b617536h","volume":"9","author":"C Capello","year":"2007","unstructured":"Capello C, Fischer U, Hungerb\u00fchler K. What is a green solvent? A comprehensive framework for the environmental assessment of solvents. Green Chem. 2007;9:927\u201334.","journal-title":"Green Chem"},{"key":"942_CR47","first-page":"53","volume":"42","author":"Y Dessouky","year":"2004","unstructured":"Dessouky Y, Hassanein H, Mohammad MA-A, Hanafy R. Normal phase high performance liquid chromatographic determination of chlorphenoxamine hydrochloride, caffeine and 8-chlorotheophylline. Bull Fac Pharm Cairo Univ. 2004;42:53\u201363.","journal-title":"Bull Fac Pharm Cairo Univ"}],"container-title":["BMC Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-023-00942-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13065-023-00942-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-023-00942-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T02:03:32Z","timestamp":1681697012000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcchem.biomedcentral.com\/articles\/10.1186\/s13065-023-00942-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,17]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["942"],"URL":"https:\/\/doi.org\/10.1186\/s13065-023-00942-1","relation":{},"ISSN":["2661-801X"],"issn-type":[{"value":"2661-801X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,17]]},"assertion":[{"value":"11 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}